Literature DB >> 20035285

Inflexibility in intramuscular triglyceride fractional synthesis distinguishes prediabetes from obesity in humans.

Leigh Perreault1, Bryan C Bergman, Devon M Hunerdosse, Mary C Playdon, Robert H Eckel.   

Abstract

Whether intramuscular triglyceride (IMTG) concentration or flux is more important in the progression to type 2 diabetes is controversial. Therefore, this study examined IMTG concentration, as well as its fractional synthesis rate (FSR), in obese people with normal glucose tolerance (NGT; n = 20) vs. obese people with prediabetes (PD; n = 19), at rest and during exercise. Insulin action and secretion were assessed using an intravenous glucose tolerance test. [U-(13)C]palmitate was infused for 4 h before and throughout 1.5 h of treadmill walking at 50% VO(2(max)). IMTG concentration was measured by gas chromatograph/mass spectrometer, and FSR by gas chromatography-combustion isotope ratio mass spectrometer, from muscle biopsies taken immediately before and after exercise. Basal IMTG concentration was higher (43 +/- 5.7 vs. 27 +/- 3.9 mg/mg dry weight, P = 0.03) and FSR trended lower (0.23 +/- 0.04 vs. 0.32 +/- 0.05/h, P = 0.075), as did insulin action (S(i); 2.9 +/- 0.43 vs. 3.3 +/- 0.35 x 10(-4)/mU/ml, P = 0.07), in PD vs. NGT. IMTG concentration did not change significantly during exercise, but was no longer different in PD vs. NGT (45 +/- 7.7 vs. 37 +/- 5.8 mg/mg dry weight, P = 0.41). IMTG FSR suppressed during exercise in NGT (-81% to 0.06 +/- 0.13/h, P = 0.02), but not PD (+4% to 0.24 +/- 0.13%/h, P = 0.95). Palmitate oxidation was similar during rest (P = 0.92) and exercise (P = 0.94) between groups, but its source appeared different with more coming from muscle at rest and plasma during exercise in NGT, whereas the converse was true in PD. Altogether, higher basal IMTG concentration that is metabolically inflexible distinguishes obese people with PD from those with NGT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20035285      PMCID: PMC3232014          DOI: 10.1038/oby.2009.454

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  43 in total

1.  Myocellular triacylglycerol breakdown in females but not in males during exercise.

Authors:  Charlotte H Steffensen; Carsten Roepstorff; Marianne Madsen; Bente Kiens
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-03       Impact factor: 4.310

2.  Intramuscular lipid content is increased in obesity and decreased by weight loss.

Authors:  B H Goodpaster; R Theriault; S C Watkins; D E Kelley
Journal:  Metabolism       Date:  2000-04       Impact factor: 8.694

3.  Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes.

Authors:  B H Goodpaster; J He; S Watkins; D E Kelley
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

4.  Kinetics of intramuscular triglyceride fatty acids in exercising humans.

Authors:  Z Guo; B Burguera; M D Jensen
Journal:  J Appl Physiol (1985)       Date:  2000-11

5.  Validation of a new procedure to determine plasma fatty acid concentration and isotopic enrichment.

Authors:  B W Patterson; G Zhao; N Elias; D L Hachey; S Klein
Journal:  J Lipid Res       Date:  1999-11       Impact factor: 5.922

Review 6.  Triglyceride content in skeletal muscle: variability and the source.

Authors:  Z Guo
Journal:  Anal Biochem       Date:  2001-09-01       Impact factor: 3.365

7.  Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise.

Authors:  E E Blaak; D P van Aggel-Leijssen; A J Wagenmakers; W H Saris; M A van Baak
Journal:  Diabetes       Date:  2000-12       Impact factor: 9.461

Review 8.  Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply.

Authors:  C Schmitz-Peiffer
Journal:  Cell Signal       Date:  2000-10       Impact factor: 4.315

9.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

10.  Sex and depot differences in adipocyte insulin sensitivity and glucose metabolism.

Authors:  Yazmin Macotela; Jeremie Boucher; Thien T Tran; C Ronald Kahn
Journal:  Diabetes       Date:  2009-01-09       Impact factor: 9.461

View more
  17 in total

1.  Acute high-fat feeding does not prevent the improvement in glucose tolerance after resistance exercise in lean individuals.

Authors:  Christopher S Shaw; Natalie M Cooper; Oliver Shaw; Paulo Salomao; Anton J M Wagenmakers
Journal:  Eur J Appl Physiol       Date:  2011-03-05       Impact factor: 3.078

Review 2.  Origins of metabolic complications in obesity: adipose tissue and free fatty acid trafficking.

Authors:  Bettina Mittendorfer
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2011-11       Impact factor: 4.294

3.  Altered intramuscular lipid metabolism relates to diminished insulin action in men, but not women, in progression to diabetes.

Authors:  Leigh Perreault; Bryan C Bergman; Devon M Hunerdosse; Robert H Eckel
Journal:  Obesity (Silver Spring)       Date:  2010-04-08       Impact factor: 5.002

4.  Mild fasting hyperglycemia shifts fuel reliance toward fat during exercise in adults with impaired glucose tolerance.

Authors:  Steven K Malin; Richard Viskochil; Corianne Oliver; Barry Braun
Journal:  J Appl Physiol (1985)       Date:  2013-04-18

5.  Skeletal muscle phosphatidylcholine and phosphatidylethanolamine are related to insulin sensitivity and respond to acute exercise in humans.

Authors:  Sean A Newsom; Joseph T Brozinick; Katja Kiseljak-Vassiliades; Allison N Strauss; Samantha D Bacon; Anna A Kerege; Hai Hoang Bui; Phil Sanders; Parker Siddall; Tao Wei; Melissa Thomas; Ming Shang Kuo; Travis Nemkov; Angelo D'Alessandro; Kirk C Hansen; Leigh Perreault; Bryan C Bergman
Journal:  J Appl Physiol (1985)       Date:  2016-03-31

6.  Intramuscular triglyceride synthesis: importance in muscle lipid partitioning in humans.

Authors:  Bryan C Bergman; Leigh Perreault; Allison Strauss; Samantha Bacon; Anna Kerege; Kathleen Harrison; Joseph T Brozinick; Devon M Hunerdosse; Mary C Playdon; William Holmes; Hai Hoang Bui; Phil Sanders; Parker Siddall; Tao Wei; Melissa K Thomas; Ming Shang Kuo; Robert H Eckel
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-10-03       Impact factor: 4.310

7.  Intracellular localization of diacylglycerols and sphingolipids influences insulin sensitivity and mitochondrial function in human skeletal muscle.

Authors:  Leigh Perreault; Sean A Newsom; Allison Strauss; Anna Kerege; Darcy E Kahn; Kathleen A Harrison; Janet K Snell-Bergeon; Travis Nemkov; Angelo D'Alessandro; Matthew R Jackman; Paul S MacLean; Bryan C Bergman
Journal:  JCI Insight       Date:  2018-02-08

8.  Sex Differences in Insulin Sensitivity are Related to Muscle Tissue Acylcarnitine But Not Subcellular Lipid Distribution.

Authors:  Josiane L Broussard; Leigh Perreault; Emily Macias; Sean A Newsom; Kathleen Harrison; Hai Hoang Bui; Paul Milligan; Kenneth D Roth; Travis Nemkov; Angelo D'Alessandro; Joseph T Brozinick; Bryan C Bergman
Journal:  Obesity (Silver Spring)       Date:  2021-03       Impact factor: 5.002

9.  Skeletal muscle carnitine loading increases energy expenditure, modulates fuel metabolism gene networks and prevents body fat accumulation in humans.

Authors:  Francis B Stephens; Benjamin T Wall; Kanagaraj Marimuthu; Chris E Shannon; Dumitru Constantin-Teodosiu; Ian A Macdonald; Paul L Greenhaff
Journal:  J Physiol       Date:  2013-07-01       Impact factor: 5.182

10.  Subcellular localisation and composition of intramuscular triacylglycerol influence insulin sensitivity in humans.

Authors:  Darcy Kahn; Leigh Perreault; Emily Macias; Simona Zarini; Sean A Newsom; Allison Strauss; Anna Kerege; Kathleen Harrison; Janet Snell-Bergeon; Bryan C Bergman
Journal:  Diabetologia       Date:  2020-10-31       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.